JBC Connect with Cosmo for Collagen Detection

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schmitz, J.
Right arrow Articles by Schaper, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schmitz, J.
Right arrow Articles by Schaper, F.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 275, Issue 17, 12848-12856, April 28, 2000

SOCS3 Exerts Its Inhibitory Function on Interleukin-6 Signal Transduction through the SHP2 Recruitment Site of gp130*

Jochen Schmitz, Manuela Weissenbach, Serge Haan, Peter C. HeinrichDagger , and Fred Schaper

From the Institut für Biochemie, Rheinisch-Westfälische Technische Hochschule Aachen, Pauwelsstrabeta e 30, D-52074 Aachen, Germany

Interleukin-6 is involved in the regulation of many biological activities such as gene expression, cell proliferation, and differentiation. The control of the termination of cytokine signaling is as important as the regulation of initiation of signal transduction pathways. Three families of proteins involved in the down-regulation of cytokine signaling have been described recently: (i) SH2 domain-containing protein-tyrosine phosphatases (SHP), (ii) suppressors of cytokine signaling (SOCS), and (iii) protein inhibitors of activated STATs (PIAS). We have analyzed the interplay of two inhibitors in the signal transduction pathway of interleukin-6 and demonstrate that the tyrosine phosphatase SHP2 and SOCS3 do not act independently but are functionally linked. The activation of one inhibitor modulates the activity of the other; Inhibition of SHP2 activation leads to increased SOCS3-mRNA levels, whereas increased expression of SOCS3 results in a reduction of SHP2 phosphorylation after activation of the interleukin-6 signal transduction pathway. Furthermore, we show that tyrosine 759 in gp130 is essential for both SHP2 and SOCS3 but not for SOCS1 to exert their inhibitory activities on interleukin-6 signal transduction. Besides SHP2, SOCS3 also interacts with the Tyr(P)-759 peptide of gp130. Taken together, our results suggest differences in the function of SOCS1 and SOCS3 and a link between SHP2 and SOCS3.


* This work was supported by grants from the Deutsche Forschungsgemeinschaft (Bonn, Germany) and the Fonds der Chemischen Industrie (Frankfurt, Germany).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed: Medical School RWTH Aachen, Department of Biochemistry, Pauwelsstrabeta e 30, D-52074 Aachen Germany. Tel.: 0049 241 80 888 30; Fax: 0049 241 88 884 28; E-mail: heinrich@rwth-aachen.de.


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
Y. Tanaka, N. Tanaka, Y. Saeki, K. Tanaka, M. Murakami, T. Hirano, N. Ishii, and K. Sugamura
c-Cbl-Dependent Monoubiquitination and Lysosomal Degradation of gp130
Mol. Cell. Biol., August 1, 2008; 28(15): 4805 - 4818.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. Zeng, H. Li, Y. Liu, Z. Zhang, Y. Zhang, and R. Yang
Tumor-Induced Suppressor of Cytokine Signaling 3 Inhibits Toll-like Receptor 3 Signaling in Dendritic Cells via Binding to Tyrosine Kinase 2
Cancer Res., July 1, 2008; 68(13): 5397 - 5404.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. D. Kalliolias and L. B. Ivashkiv
IL-27 Activates Human Monocytes via STAT1 and Suppresses IL-10 Production but the Inflammatory Functions of IL-27 Are Abrogated by TLRs and p38
J. Immunol., May 1, 2008; 180(9): 6325 - 6333.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. Zhao, C. Lee, R. Piganis, C. Plumlee, N. de Weerd, P. J. Hertzog, and C. Schindler
A Conserved IFN-{alpha} Receptor Tyrosine Motif Directs the Biological Response to Type I IFNs
J. Immunol., April 15, 2008; 180(8): 5483 - 5489.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
H. Chen, T. Ordog, J. Chen, D. L. Young, M. R. Bardsley, D. Redelman, S. M. Ward, and K. M. Sanders
Differential gene expression in functional classes of interstitial cells of Cajal in murine small intestine
Physiol Genomics, November 14, 2007; 31(3): 492 - 509.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Brender, G. M. Tannahill, B. J. Jenkins, J. Fletcher, R. Columbus, C. J. M. Saris, M. Ernst, N. A. Nicola, D. J. Hilton, W. S. Alexander, et al.
Suppressor of cytokine signaling 3 regulates CD8 T-cell proliferation by inhibition of interleukins 6 and 27
Blood, October 1, 2007; 110(7): 2528 - 2536.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
A. Herrmann, M. Vogt, M. Monnigmann, T. Clahsen, U. Sommer, S. Haan, V. Poli, P. C. Heinrich, and G. Muller-Newen
Nucleocytoplasmic shuttling of persistently activated STAT3
J. Cell Sci., September 15, 2007; 120(18): 3249 - 3261.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. J. Murray
The JAK-STAT Signaling Pathway: Input and Output Integration
J. Immunol., March 1, 2007; 178(5): 2623 - 2629.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Ehlting, W. S. Lai, F. Schaper, E. D. Brenndorfer, R.-J. Matthes, P. C. Heinrich, S. Ludwig, P. J. Blackshear, M. Gaestel, D. Haussinger, et al.
Regulation of Suppressor of Cytokine Signaling 3 (SOCS3) mRNA Stability by TNF-{alpha} Involves Activation of the MKK6/p38MAPK/MK2 Cascade
J. Immunol., March 1, 2007; 178(5): 2813 - 2826.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Lu, S. Fukuyama, R. Yoshida, T. Kobayashi, K. Saeki, H. Shiraishi, A. Yoshimura, and G. Takaesu
Loss of SOCS3 Gene Expression Converts STAT3 Function from Anti-apoptotic to Pro-apoptotic
J. Biol. Chem., December 1, 2006; 281(48): 36683 - 36690.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. C. El Kasmi, J. Holst, M. Coffre, L. Mielke, A. de Pauw, N. Lhocine, A. M. Smith, R. Rutschman, D. Kaushal, Y. Shen, et al.
General Nature of the STAT3-Activated Anti-Inflammatory Response
J. Immunol., December 1, 2006; 177(11): 7880 - 7888.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
K. E. Jie, M. C. Verhaar, M.-J. M. Cramer, K. van der Putten, C. A. J. M. Gaillard, P. A. Doevendans, H. A. Koomans, J. A. Joles, and B. Braam
Erythropoietin and the cardiorenal syndrome: cellular mechanisms on the cardiorenal connectors
Am J Physiol Renal Physiol, November 1, 2006; 291(5): F932 - F944.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
W. A. Sands, H. D. Woolson, G. R. Milne, C. Rutherford, and T. M. Palmer
Exchange Protein Activated by Cyclic AMP (Epac)-Mediated Induction of Suppressor of Cytokine Signaling 3 (SOCS-3) in Vascular Endothelial Cells.
Mol. Cell. Biol., September 1, 2006; 26(17): 6333 - 6346.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
H.-H. Oberg, D. Wesch, S. Grussel, S. Rose-John, and D. Kabelitz
Differential expression of CD126 and CD130 mediates different STAT-3 phosphorylation in CD4+CD25- and CD25high regulatory T cells
Int. Immunol., April 1, 2006; 18(4): 555 - 563.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Stross, S. Radtke, T. Clahsen, C. Gerlach, R. Volkmer-Engert, F. Schaper, P. C. Heinrich, and H. M. Hermanns
Oncostatin M Receptor-mediated Signal Transduction Is Negatively Regulated by SOCS3 through a Receptor Tyrosine-independent Mechanism
J. Biol. Chem., March 31, 2006; 281(13): 8458 - 8468.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Qasimi, A. Ming-Lum, A. Ghanipour, C. J. Ong, M. E. Cox, J. Ihle, N. Cacalano, A. Yoshimura, and A. L-F. Mui
Divergent Mechanisms Utilized by SOCS3 to Mediate Interleukin-10 Inhibition of Tumor Necrosis Factor {alpha} and Nitric Oxide Production by Macrophages
J. Biol. Chem., March 10, 2006; 281(10): 6316 - 6324.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
A. Forrai, K. Boyle, A. H. Hart, L. Hartley, S. Rakar, T. A. Willson, K. M. Simpson, A. W. Roberts, W. S. Alexander, A. K. Voss, et al.
Absence of Suppressor of Cytokine Signalling 3 Reduces Self-Renewal and Promotes Differentiation in Murine Embryonic Stem Cells
Stem Cells, March 1, 2006; 24(3): 604 - 614.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
K Lindberg, S G Ronn, D Tornehave, H Richter, J A Hansen, J Romer, M Jackerott, and N Billestrup
Regulation of pancreatic {beta}-cell mass and proliferation by SOCS-3
J. Mol. Endocrinol., October 1, 2005; 35(2): 231 - 243.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
U. Sommer, C. Schmid, R. M. Sobota, U. Lehmann, N. J. Stevenson, J. A. Johnston, F. Schaper, P. C. Heinrich, and S. Haan
Mechanisms of SOCS3 Phosphorylation upon Interleukin-6 Stimulation: CONTRIBUTIONS OF Src- AND RECEPTOR-TYROSINE KINASES
J. Biol. Chem., September 9, 2005; 280(36): 31478 - 31488.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. L. Dunn, M. Bjornholm, S. H. Bates, Z. Chen, M. Seifert, and M. G. Myers Jr.
Feedback Inhibition of Leptin Receptor/Jak2 Signaling via Tyr1138 of the Leptin Receptor and Suppressor of Cytokine Signaling 3
Mol. Endocrinol., April 1, 2005; 19(4): 925 - 938.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Liu, C. Liang, Z. Liang, K. Tus, and E. K. Wakeland
Sle1ab Mediates the Aberrant Activation of STAT3 and Ras-ERK Signaling Pathways in B Lymphocytes
J. Immunol., February 1, 2005; 174(3): 1630 - 1637.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Qing, A. P. Costa-Pereira, D. Watling, and G. R. Stark
Role of Tyrosine 441 of Interferon-{gamma} Receptor Subunit 1 in SOCS-1-mediated Attenuation of STAT1 Activation
J. Biol. Chem., January 21, 2005; 280(3): 1849 - 1853.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X.-P. Yang, U. Albrecht, V. Zakowski, R. M. Sobota, D. Haussinger, P. C. Heinrich, S. Ludwig, J. G. Bode, and F. Schaper
Dual Function of Interleukin-1{beta} for the Regulation of Interleukin-6-induced Suppressor of Cytokine Signaling 3 Expression
J. Biol. Chem., October 22, 2004; 279(43): 45279 - 45289.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. G. Hunter, A. Jacob, L. C. O'Donnell, A. Agler, L. J. Druhan, K. M. Coggeshall, and B. R. Avalos
Loss of SHIP and CIS Recruitment to the Granulocyte Colony-Stimulating Factor Receptor Contribute to Hyperproliferative Responses in Severe Congenital Neutropenia/Acute Myelogenous Leukemia
J. Immunol., October 15, 2004; 173(8): 5036 - 5045.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G.-J. M. van de Geijn, J. Gits, L. H. J. Aarts, C. Heijmans-Antonissen, and I. P. Touw
G-CSF receptor truncations found in SCN/AML relieve SOCS3-controlled inhibition of STAT5 but leave suppression of STAT3 intact
Blood, August 1, 2004; 104(3): 667 - 674.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Anneren, C. A. Cowan, and D. A. Melton
The Src Family of Tyrosine Kinases Is Important for Embryonic Stem Cell Self-renewal
J. Biol. Chem., July 23, 2004; 279(30): 31590 - 31598.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
G.-J. M. van de Geijn, J. Gits, and I. P. Touw
Distinct activities of suppressor of cytokine signaling (SOCS) proteins and involvement of the SOCS box in controlling G-CSF signaling
J. Leukoc. Biol., July 1, 2004; 76(1): 237 - 244.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Goldshmit, C. E. Walters, H. J. Scott, C. J. Greenhalgh, and A. M. Turnley
SOCS2 Induces Neurite Outgrowth by Regulation of Epidermal Growth Factor Receptor Activation
J. Biol. Chem., April 16, 2004; 279(16): 16349 - 16355.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Gatto, C. Berlato, V. Poli, S. Tininini, I. Kinjyo, A. Yoshimura, M. A. Cassatella, and F. Bazzoni
Analysis of SOCS-3 Promoter Responses to Interferon {gamma}
J. Biol. Chem., April 2, 2004; 279(14): 13746 - 13754.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Bayle, S. Letard, R. Frank, P. Dubreuil, and P. De Sepulveda
Suppressor of Cytokine Signaling 6 Associates with KIT and Regulates KIT Receptor Signaling
J. Biol. Chem., March 26, 2004; 279(13): 12249 - 12259.
[Abstract] [Full Text] [PDF]


Home page
GENES CELLSHome page
N. Higashi, H. Kunimoto, S. Kaneko, T. Sasaki, M. Ishii, H. Kojima, and K. Nakajima
Cytoplasmic c-Fos induced by the YXXQ-derived STAT3 signal requires the co-operative MEK/ERK signal for its nuclear translocation
Genes Cells, March 1, 2004; 9(3): 233 - 242.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
B. J. Jenkins, D. Grail, M. Inglese, C. Quilici, S. Bozinovski, P. Wong, and M. Ernst
Imbalanced gp130-Dependent Signaling in Macrophages Alters Macrophage Colony-Stimulating Factor Responsiveness via Regulation of c-fms Expression
Mol. Cell. Biol., February 15, 2004; 24(4): 1453 - 1463.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Wormald and D. J. Hilton
Inhibitors of Cytokine Signal Transduction
J. Biol. Chem., January 9, 2004; 279(2): 821 - 824.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Brocke-Heidrich, A. K. Kretzschmar, G. Pfeifer, C. Henze, D. Loffler, D. Koczan, H.-J. Thiesen, R. Burger, M. Gramatzki, and F. Horn
Interleukin-6-dependent gene expression profiles in multiple myeloma INA-6 cells reveal a Bcl-2 family-independent survival pathway closely associated with Stat3 activation
Blood, January 1, 2004; 103(1): 242 - 251.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
V. C. Calegari, R. M. N. Bezerra, M. A. Torsoni, A. S. Torsoni, K. G. Franchini, M. J. A. Saad, and L. A. Velloso
Suppressor of Cytokine Signaling 3 Is Induced by Angiotensin II in Heart and Isolated Cardiomyocytes, and Participates in Desensitization
Endocrinology, October 1, 2003; 144(10): 4586 - 4596.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. Pal and A. Sahu
Leptin Signaling in the Hypothalamus during Chronic Central Leptin Infusion
Endocrinology, September 1, 2003; 144(9): 3789 - 3798.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Haan, P. Ferguson, U. Sommer, M. Hiremath, D. W. McVicar, P. C. Heinrich, J. A. Johnston, and N. A. Cacalano
Tyrosine Phosphorylation Disrupts Elongin Interaction and Accelerates SOCS3 Degradation
J. Biol. Chem., August 22, 2003; 278(34): 31972 - 31979.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. G. Bode, J. Schweigart, J. Kehrmann, C. Ehlting, F. Schaper, P. C. Heinrich, and D. Haussinger
TNF-{alpha} Induces Tyrosine Phosphorylation and Recruitment of the Src Homology Protein-Tyrosine Phosphatase 2 to the gp130 Signal-Transducing Subunit of the IL-6 Receptor Complex
J. Immunol., July 1, 2003; 171(1): 257 - 266.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Mahboubi, N. C. Kirkiles-Smith, J. Karras, and J. S. Pober
Desensitization of Signaling by Oncostatin M in Human Vascular Cells Involves Cytoplasmic Tyr Residue 759 in gp130 but Is Not Mediated by Either Src Homology 2 Domain-containing Tyrosine Phosphatase 2 or Suppressor of Cytokine Signaling 3
J. Biol. Chem., June 27, 2003; 278(27): 25014 - 25023.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. J. Senn, P. J. Klover, I. A. Nowak, T. A. Zimmers, L. G. Koniaris, R. W. Furlanetto, and R. A. Mooney
Suppressor of Cytokine Signaling-3 (SOCS-3), a Potential Mediator of Interleukin-6-dependent Insulin Resistance in Hepatocytes
J. Biol. Chem., April 11, 2003; 278(16): 13740 - 13746.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Niemand, A. Nimmesgern, S. Haan, P. Fischer, F. Schaper, R. Rossaint, P. C. Heinrich, and G. Muller-Newen
Activation of STAT3 by IL-6 and IL-10 in Primary Human Macrophages Is Differentially Modulated by Suppressor of Cytokine Signaling 3
J. Immunol., March 15, 2003; 170(6): 3263 - 3272.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
A. Matsumoto, Y.-i. Seki, R. Watanabe, K. Hayashi, J. A. Johnston, Y. Harada, R. Abe, A. Yoshimura, and M. Kubo
A Role of Suppressor of Cytokine Signaling 3 (SOCS3/CIS3/SSI3) in CD28-mediated Interleukin 2 Production
J. Exp. Med., February 17, 2003; 197(4): 425 - 436.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Sasaki, K. Inagaki-Ohara, T. Yoshida, A. Yamanaka, M. Sasaki, H. Yasukawa, A. E. Koromilas, and A. Yoshimura
The N-terminal Truncated Isoform of SOCS3 Translated from an Alternative Initiation AUG Codon under Stress Conditions Is Stable Due to the Lack of a Major Ubiquitination Site, Lys-6
J. Biol. Chem., January 17, 2003; 278(4): 2432 - 2436.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
U. Lehmann, J. Schmitz, M. Weissenbach, R. M. Sobota, M. Hortner, K. Friederichs, I. Behrmann, W. Tsiaris, A. Sasaki, J. Schneider-Mergener, et al.
SHP2 and SOCS3 Contribute to Tyr-759-dependent Attenuation of Interleukin-6 Signaling through gp130
J. Biol. Chem., January 3, 2003; 278(1): 661 - 671.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
T. Atsumi, K. Ishihara, D. Kamimura, H. Ikushima, T. Ohtani, S. Hirota, H. Kobayashi, S.-J. Park, Y. Saeki, Y. Kitamura, et al.
A Point Mutation of Tyr-759 in Interleukin 6 Family Cytokine Receptor Subunit gp130 Causes Autoimmune Arthritis
J. Exp. Med., October 7, 2002; 196(7): 979 - 990.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
I. Sakai, K. Takeuchi, H. Yamauchi, H. Narumi, and S. Fujita
Constitutive expression of SOCS3 confers resistance to IFN-alpha in chronic myelogenous leukemia cells
Blood, September 26, 2002; 100(8): 2926 - 2931.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
T. Yoshida, T. Hanada, T. Tokuhisa, K.-i. Kosai, M. Sata, M. Kohara, and A. Yoshimura
Activation of STAT3 by the Hepatitis C Virus Core Protein Leads to Cellular Transformation
J. Exp. Med., September 2, 2002; 196(5): 641 - 653.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Lang, D. Patel, J. J. Morris, R. L. Rutschman, and P. J. Murray
Shaping Gene Expression in Activated and Resting Primary Macrophages by IL-10
J. Immunol., September 1, 2002; 169(5): 2253 - 2263.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Hortner, U. Nielsch, L. M. Mayr, J. A. Johnston, P. C. Heinrich, and S. Haan
Suppressor of Cytokine Signaling-3 Is Recruited to the Activated Granulocyte-Colony Stimulating Factor Receptor and Modulates its Signal Transduction
J. Immunol., August 1, 2002; 169(3): 1219 - 1227.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. T. Ahmed, A. Mayer, J.-D. Ji, and L. B. Ivashkiv
Inhibition of IL-6 signaling by a p38-dependent pathway occurs in the absence of new protein synthesis
J. Leukoc. Biol., July 1, 2002; 72(1): 154 - 162.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Berlato, M. A. Cassatella, I. Kinjyo, L. Gatto, A. Yoshimura, and F. Bazzoni
Involvement of Suppressor of Cytokine Signaling-3 as a Mediator of the Inhibitory Effects of IL-10 on Lipopolysaccharide-Induced Macrophage Activation
J. Immunol., June 15, 2002; 168(12): 6404 - 6411.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Cebo, V. Durier, P. Lagant, E. Maes, D. Florea, T. Lefebvre, G. Strecker, G. Vergoten, and J.-P. Zanetta
Function and Molecular Modeling of the Interaction between Human Interleukin 6 and Its HNK-1 Oligosaccharide Ligands
J. Biol. Chem., March 29, 2002; 277(14): 12246 - 12252.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Radtke, H. M. Hermanns, C. Haan, H. Schmitz-Van de Leur, H. Gascan, P. C. Heinrich, and I. Behrmann
Novel Role of Janus Kinase 1 in the Regulation of Oncostatin M Receptor Surface Expression
J. Biol. Chem., March 22, 2002; 277(13): 11297 - 11305.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Mahboubi and J. S. Pober
Activation of Signal Transducer and Activator of Transcription 1 (STAT1) Is Not Sufficient for the Induction of STAT1-dependent Genes in Endothelial Cells. COMPARISON OF INTERFERON-gamma AND ONCOSTATIN M
J. Biol. Chem., March 1, 2002; 277(10): 8012 - 8021.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page